Pfizer Wants FDA To Stop Sponsor Promos From Implying Biosimilars Are Inferior

Citizen petition requests agency guidance that specifies what communications are false and misleading; Pfizer cites a Janssen Remicade brochure and Amgen YouTube video that suggest switching to biosimilars could lead to different outcomes.

Futuristic portable device and many pictures.

Seeking to boost biosimilar uptake, Pfizer Inc. is asking FDA to issue guidance to deter innovator companies from suggesting that biosimilars are not as safe and effective as reference biologics.

In an Aug. 22 citizen petition, Pfizer requests that the agency publish a guidance document that describes the types...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics